友邦保險(01299.HK)股價搶高逾4% 第三季新業務價值按固定匯率計升7%
友邦保險(01299.HK)今日高開0.59%後持向上,盤中曾最高見62.5元,現報62.25元,升4.71%,成交898.5萬股,涉資5.46億元。高盛表示,友邦上季新業務價值符合該行預期,以固定匯率基準計按年升7%,略優於市場預期,旗下各區域新業務價值均增長,顯示業務正面,重申對其「買入」投資評級(「確信買入」名單)及目標價93元。
友邦保險公布截至今年9月底止第三季新業務價值錄7.41億美元,以固定匯率基準計按年升7%,按實質匯率計升1%。按實質匯率計,集團第三季新業務價值利潤率為58.1%,按年跌0.4個百分點;年化新保費升2%至12.71億美元;總加權保費收入跌3%至86.56億美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.